Research Article

Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications

Volume: 16 Number: 1 March 19, 2026
EN

Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications

Abstract

Aim: Chronic pain management is crucial in geriatric pain management. Sympathetic ganglion blocks are minimally invasive procedures performed in pain conditions associated with the sympathetic system, such as cancer-related, ischemic, and neuropathic pain. Data regarding the effectiveness and safety of these blocks in elderly patients are limited. This study evaluates the effects of sympathetic ganglion blocks on pain intensity, opioid consumption, and complications. Materials and Methods: This retrospective cohort study included 417 patients aged ≥65 years who underwent a sympathetic ganglion block. Procedures included stellate, thoracic and lumbar sympathetic, celiac, splanchnic, hypogastric, and impar ganglion blocks. Pain intensity was assessed using the Visual Analog Scale (VAS), and opioid use was converted to morphine equivalents. Complications were classified as minor or major. Results: Visual analog scale scores significantly decreased from 7.88±0.89 at baseline to 3.98±1.30 at 1 month and 5.76±1.51 at 3 months (p <0.001). Daily opioid consumption was reduced from 90.38±99.45 mg/day to 36.39±33.36 mg/day at 3 months (p <0.001), with the most pronounced decrease in malignant patients. Complications were observed in 35% of patients, primarily minor (e.g., orthostatic hypotension, Horner syndrome), while major complications were rare (e.g., pneumothorax). Conclusion: Sympathetic ganglion blocks effectively reduce pain and opioid use in elderly patients with chronic pain of malignant and nonmalignant origins. Although complication rates are noteworthy, safety can be ensured with careful patient selection and follow-up.

Keywords

References

  1. 1. Kong F. Aging trend of the world. In: Hoshi T, Kodama S, editors. The structure of healthy life determinants. Vol 18. International perspectives on aging. Cham: Springer; 2018. p. 15-28.
  2. 2. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331–1346. https://doi.org/10.1111/j.1532-5415.2009.02376.x
  3. 3. Borsheski R, Johnson QL. Pain management in the geriatric population. Mo Med. 2014;111(6):508–511.
  4. 4. Helme RD, Gibson SJ. The epidemiology of pain in elderly people. Clin Geriatr Med. 2001;17(3):417–431. https://doi.org/10.1016/S0749-0690(05)70078-1
  5. 5. Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42 Suppl 1:i1-i57. https://doi.org/10.1093/ ageing/afs200
  6. 6. Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. Clin Interv Aging. 2013;8:37–46. https://doi.org/10.2147/ CIA.S30165
  7. 7. Tetzlaff JE. Cousins and Bridenbaugh’s neural blockade in clinical anesthesia and pain medicine. Mayo Clin Proc. 2010;85(7):e51. https://doi.org/10.4065/mcp.2010.0230
  8. 8. Gunduz OH, Kenis-Coskun O. Ganglion blocks as a treatment of pain: current perspectives. J Pain Res. 2017;10:2815–2826.https://doi.org/10.2147/JPR.S134775

Details

Primary Language

English

Subjects

Anaesthesiology

Journal Section

Research Article

Publication Date

March 19, 2026

Submission Date

June 19, 2025

Acceptance Date

February 10, 2026

Published in Issue

Year 2026 Volume: 16 Number: 1

APA
Başarı, A., Ünal-Özer, H. A., Özgencil, G. E., & Aşık, İ. (2026). Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications. Kafkas Journal of Medical Sciences, 16(1), 96-102. https://izlik.org/JA98JZ22UN
AMA
1.Başarı A, Ünal-Özer HA, Özgencil GE, Aşık İ. Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications. Kafkas Journal of Medical Sciences. 2026;16(1):96-102. https://izlik.org/JA98JZ22UN
Chicago
Başarı, Ahmet, Hanzade Aybüke Ünal-Özer, Güngör Enver Özgencil, and İbrahim Aşık. 2026. “Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications”. Kafkas Journal of Medical Sciences 16 (1): 96-102. https://izlik.org/JA98JZ22UN.
EndNote
Başarı A, Ünal-Özer HA, Özgencil GE, Aşık İ (March 1, 2026) Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications. Kafkas Journal of Medical Sciences 16 1 96–102.
IEEE
[1]A. Başarı, H. A. Ünal-Özer, G. E. Özgencil, and İ. Aşık, “Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications”, Kafkas Journal of Medical Sciences, vol. 16, no. 1, pp. 96–102, Mar. 2026, [Online]. Available: https://izlik.org/JA98JZ22UN
ISNAD
Başarı, Ahmet - Ünal-Özer, Hanzade Aybüke - Özgencil, Güngör Enver - Aşık, İbrahim. “Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications”. Kafkas Journal of Medical Sciences 16/1 (March 1, 2026): 96-102. https://izlik.org/JA98JZ22UN.
JAMA
1.Başarı A, Ünal-Özer HA, Özgencil GE, Aşık İ. Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications. Kafkas Journal of Medical Sciences. 2026;16:96–102.
MLA
Başarı, Ahmet, et al. “Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications”. Kafkas Journal of Medical Sciences, vol. 16, no. 1, Mar. 2026, pp. 96-102, https://izlik.org/JA98JZ22UN.
Vancouver
1.Ahmet Başarı, Hanzade Aybüke Ünal-Özer, Güngör Enver Özgencil, İbrahim Aşık. Sympathetic Ganglion Blocks in the Elderly: Efficacy, Safety, Analgesic Consumption, and Complications. Kafkas Journal of Medical Sciences [Internet]. 2026 Mar. 1;16(1):96-102. Available from: https://izlik.org/JA98JZ22UN